Consistent with this work, we observed that Cox-2-controlled OAds were as effective at killing breast cancer cells as the Cox-2-positive A549 control cell line, indicating that breast cancer cells upregulate the Cox-2 promoter. The gene discussed is PTGS2; the disease is breast carcinoma.